A study to evaluate prescribing pattern of antibiotics among patients of urinary tract infection with preexisting renal disorders in a tertiary care hospital


  • Dinesh K. Dhodi Department of Pharmacology, Grant Government Medical College & Sir JJ Group of Hospitals, Mumbai, Maharashtra, India
  • Sarita Jaiswar Department of Pharmacology, Grant Government Medical College & Sir JJ Group of Hospitals, Mumbai, Maharashtra, India
  • Sagar B. Bhagat Department of Pharmacology, Grant Government Medical College & Sir JJ Group of Hospitals, Mumbai, Maharashtra, India
  • Rohini S. Gambre Department of Pharmacology, Grant Government Medical College & Sir JJ Group of Hospitals, Mumbai, Maharashtra, India


Antibiotic, Renal disorder, Urinary tract infection


Background: Urinary tract infection (UTI) is one of the most common bacterial infections encountered and treated worldwide. The objective was to determine the incidence, culture-sensitivity status, prescription pattern of antibiotics and response to various antibiotics and other therapeutic considerations in patients of complicated UTI (cUTI).

Methods: The observational prospective analytical study conducted in Department of Nephrology, Grant Government Medical College and Sir JJ Group of Hospitals, Mumbai.

Results: A total percentage of patients having UTI was 13.08%. Of these 200 patients, 119 patients were female (60%) and 81 patients were male (41 %). Among male, the prevalence was seen more in geriatric age group and among female in adult group. Symptomatologically, fever was the most common symptom. Among male, diabetes mellitus was most commonly associated with cUTI whereas recurrent UTI were more common among female. Of the 200 patients, culture sensitivity was done in 133 patients. Escherichia coli was found to be the most common organism.Quinolones were the most commonly prescribed first line drug followed by beta-lactamase inhibitors. Combinations such as cefoperazone + linezolid were the most commonly prescribed second-line drug, followed by combination of ceftriaxone or cefoperazone with metronidazole.Paracetamol was the most common non antibiotic support given.

Conclusions: The results of this study may not be representative of the general population; but UTIs are often treated empirically, and susceptibility tests are often carried out only when the patient has failed one or more courses of antibiotics.


Sibi G, Aheibam PD, Fouzia K, Patil BR. Prevalence microbiologic profile of urinary tract infection and its treatment with trimethoprim in diabetic patients. Res J Microbiol. 2011;6(6):543-51.

Wasnik DD, Tumane PM. Prevalence and antibacterial susceptibility pattern of urinary tract infection causing human pathogenic bacteria. Asian J Biomed Pharm Sci. 2012;2(15):1-3.

Sussman M. In: Hausler WJ Jr, Sussman M editors. Topley and Wilson’s Microbiology and Microbial Infections. 9th Edition. London: Arnold; 1998: 601-21.

Stamm WE, Norrby SR. Urinary tract infections: disease panorama and challenges. J Infect Dis. 2001;183 Suppl 1:S1-4.

Patel S, Taviad PP, Sinha M, Javadekar TB, Chaudhari VP. Urinary tract infections (UTI) among patients At G.G. Hospital & Medical College, Jamnagar. Natl J Community Med. 2012;3(1):138-45.

Akhtar N. Urinary tract bacterial pathogens their antimicrobial susceptibility patterns at Bahawalpur. Professional. 2000;7(2):131-7.

Ahmed AB, Ghadeer AS. Recurrent urinary tract infections management in women a review. Sultan Qaboos Univ Med J. 2013;13(3):359-67.

Maripandi A, Ali A, Salamah A, Amuthan M. Prevalence and antibiotics susceptibility of uropathogens in patients from a rural environment, Tamilnadu. Am J Infect Dis. 2010;6(2):29-33.

Bankole H O, Omoregie R, Olley M, Joshua A. Urinary tract infection in a rural community of Nigeria. N Am J Med Sci. 2011;3(2):75-7.

Rahn DD. Urinary tract infections: contemporary management. Urol Nurs. 2008;28(5):333-41.

Foxman B, Barlow R, D’Arcy H, Gillespie B, Sobel JD. Urinary tract infection: self-reported incidence and associated costs. Ann Epidemiol. 2000;10(8):509-15.

Foxman B. Epidemiology of urinary tract infections: incidence, morbidity, and economic costs. Am J Med. 2002;113 Suppl 1A:5S-13.

Mathai D, Jones RN, Pfaller MA, SENTRY Participant Group North America. Epidemiology and frequency of resistance among pathogens causing urinary tract infections in 1,510 hospitalized patients: a report from the SENTRY antimicrobial surveillance program (North America). Diagn Microbiol Infect Dis. 2001;40:129-36.

Bryan CS, Reynolds KL. Community-acquired bacteremic urinary tract infection: epidemiology and outcome. J Urol. 1984;132(3):490-3.

Kahlmeter G, ECO.SENS. An international survey of the antimicrobial susceptibility of pathogens from uncomplicated urinary tract infections: the ECO.SENS Project. J Antimicrob Chemother. 2003;51(1):69-76.

Shanthi J, Kayathri S. Incidence, distribution and antibiogram of uropathogens isolated from patients with urinary tract infections. Adv Appl Sci Res. 2012;3(6):3410-4.

Sanchez GV, Master RN, Karlowsky JA, Bordon JM. In vitro antimicrobial resistance of urinary Escherichia coli isolates among U.S. outpatients from 2000 to 2010. Antimicrob Agents Chemother. 2012;56(4):2181-3.

Qi C, Pilla V, Yu JH, Reed K. Changing prevalence of Escherichia coli with CTX-M-type extended-spectrum beta-lactamases in outpatient urinary E. coli between 2003 and 2008. Diagn Microbiol Infect Dis. 2010;67(1):87-91.

Gupta N, Limbago BM, Patel JB, Kallen AJ. Carbapenem-resistant Enterobacteriaceae: epidemiology and prevention. Clin Infect Dis. 2011;53(1):60-7.

Kumarasamy KK, Toleman MA, Walsh TR, Bagaria J, Butt F, Balakrishnan R, et al. Emergence of a new antibiotic resistance mechanism in India, Pakistan, and the UK: a molecular, biological, and epidemiological study. Lancet Infect Dis. 2010;10(9):597-602.

Gupta K, Hooton TM, Naber KG, Wullt B, Colgan R, Miller LG, et al. International clinical practice guidelines for the treatment of acute uncomplicated cystitis and pyelonephritis in women: a 2010 update by the Infectious Diseases Society of America and the European Society for Microbiology and Infectious Diseases. Clin Infect Dis. 2011;52(5):e103-20.

Hooton TM, Bradley SF, Cardenas DD, Colgan R, Geerlings SE, Rice JC, et al. Diagnosis, prevention, and treatment of catheter-associated urinary tract infection in adults: 2009 International Clinical Practice Guidelines from the Infectious Diseases Society of America. Clin Infect Dis. 2010;50(5):625-63.

Hillier SL, Magee JT, Howard AJ, Palmer SR. How strong is the evidence that antibiotic use is a risk factor for antibiotic-resistant, community-acquired urinary tract infection? J Antimicrob Chemother. 2002;50(2):241-7.

Steinke D, Davey P. Association between antibiotic resistance and community prescribing: a critical review of bias and confounding in published studies. Clin Infect Dis. 2001;33 Suppl 3:S193-205.

Hillier S, Roberts Z, Dunstan F, Butler C, Howard A, Palmer S. Prior antibiotics and risk of antibiotic-resistant community-acquired urinary tract infection: a case-control study. J Antimicrob Chemother. 2007;60(1):92-9.

Rubenstein JN, Schaeffer AJ. Managing complicated urinary tract infections: the urologic view. Infect Dis Clin North Am. 2003;17(2):333-51.

Pargavi B, Mekala T, Thamarai Selvi A, Moorthy K. Prevalence of urinary tract infection among diabetics patients in Vandavasi, Tamilnadu, India. Int J Biol Technol. 2011;2(2):42-5.

Arul Prakasam KC, Dileesh Kumar KG, Vijayan M. A cross sectional study on distribution of urinary tract infection and their antibiotic utilizations pattern in Kerala. Int J PharmTech Res. 2012;4(3):1309-16.

Mahesh E, Ramesh D, Indumathi VA, Punith K, Raj K, Anupama HA. Complicated urinary tract infection in a tertiary care centre in South India. Al ameen J Med Sci. 2010;3(2):120-7.

Arslan H, Azap OK, Ergönül O, Timurkaynak F, Urinary Tract Infection Study Group. Risk factors for ciprofloxacin resistance among Escherichia coli strains isolated from community-acquired urinary tract infections in Turkey. J Antimicrob Chemother. 2005;56(5):914-8.

Chen SS, Chen KK, Lin AT, Chang YH, Wu HH, Hsu TH, et al. Complicated urinary tract infection: analysis of 179 patients. Zhonghua Yi Xue Za Zhi (Taipei). 1998;61(11):651-6.

Peterson J, Kaul S, Khashab M, Fisher A, Kahn JB. Identification and pretherapy susceptibility of pathogens in patients with complicated urinary tract infection or acute pyelonephritis enrolled in a clinical study in the United States from November 2004 through April 2006. Clin Ther. 2007;29(10):2215-21.

Nicolle LE. A practical guide to the management of complicated urinary tract infection. Drugs. 1997;53(4):583-92.




How to Cite

Dhodi, D. K., Jaiswar, S., Bhagat, S. B., & Gambre, R. S. (2017). A study to evaluate prescribing pattern of antibiotics among patients of urinary tract infection with preexisting renal disorders in a tertiary care hospital. International Journal of Basic & Clinical Pharmacology, 3(4), 687–691. Retrieved from https://www.ijbcp.com/index.php/ijbcp/article/view/1054



Original Research Articles